𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aberrations of growth factor control in metastatic follicular thyroid cancerin vitro

✍ Scribed by Thomas Hoelting; Andreas Zielke; Allan E. Siperstein; Orlo H. Clark; Quan -Yang Duh


Publisher
Springer
Year
1994
Tongue
English
Weight
867 KB
Volume
12
Category
Article
ISSN
0262-0898

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Effects of epidermal growth factor, insu
✍ Reed, Michael L. ;Estrada, Jose L. ;Illera, Maria J. ;Petters, Robert M. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB

## Abstract Undefined follicular factors that may influence nuclear maturation and/or cytoplasmic maturation are required during in vitro maturation of pig oocytes. Epidermal growth factor (EGF), insulin‐like growth factor‐I (IGF‐I), and dialysed porcine follicular fluid (dpFF) were evaluated for t

Metastatic but not primary melanoma cell
✍ Ulrich Rodeck; Meenhard Herlyn; Hans D. Menssen; Richard W. Furlanetto; Hilary K 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 536 KB

Five out of 6 cell lines derived from metastatic melanoma lesions grew in a chemically defined base medium consisting of a mixture of calcium-supplemented MCDB 153 and L 15 media in the absence of any polypeptide growth factors. In contrast, under these conditions no growth was seen in any of 5 prim

Hypoxic response elements control expres
✍ Bo Jiang; Hongyan Dong; Zhongming Zhang; Wei Wang; Yiqian Zhang; Xiahong Xu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB

## Abstract ## Background Vascular endothelial growth factor (VEGF) gene transfer with recombinant adeno‐associated viral (rAAV) vector for ischemia heart disease therapy is being increasingly studied. However, uncontrolled long‐term expression of VEGF may cause some side effects. Therefore, an at

Effect of controlled release of fibrobla
✍ Shingo Nakamura; Masaki Nambu; Takamitsu Ishizuka; Hidemi Hattori; Yasuhiro Kana 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

## Abstract We produced a chitosan/fucoidan micro complex‐hydrogel as a carrier for controlled release of heparin binding growth factors such as fibroblast growth factor (FGF)‐2. Material consisting of a soluble chitosan (CH‐LA) mixed with fucoidan yielded a water‐insoluble and injectable hydrogel